NLG919 100mg 100mg | Purity Not Available
Adooq Bioscience
NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.
More Information Supplier PageSearch Results
Ro 48-8071 fumarate 50mg 50mg | Purity Not Available
Adooq Bioscience
Ro 48-8071 inhibits cholesterol biosynthesis at the level of 2,3-oxidosqualene cyclase (OSC). It blocks OSC and cholesterol synthesis in HepG2 cells in the nanomolar range. A novel lipid lowering agent.
More Information Supplier PageRo 48-8071 fumarate 25mg 25mg | Purity Not Available
Adooq Bioscience
Ro 48-8071 inhibits cholesterol biosynthesis at the level of 2,3-oxidosqualene cyclase (OSC). It blocks OSC and cholesterol synthesis in HepG2 cells in the nanomolar range. A novel lipid lowering agent.
More Information Supplier PageRo 48-8071 fumarate 10mg 10mg | Purity Not Available
Adooq Bioscience
Ro 48-8071 inhibits cholesterol biosynthesis at the level of 2,3-oxidosqualene cyclase (OSC). It blocks OSC and cholesterol synthesis in HepG2 cells in the nanomolar range. A novel lipid lowering agent.
More Information Supplier PageUNC0379 5mg 5mg | Purity Not Available
Adooq Bioscience
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. Its affinity to SETD8 was confirmed by ITC (isothermal titration calorimetry) and SPR (surface plasmon resonance) studies.
More Information Supplier PageUNC0379 25mg 25mg | Purity Not Available
Adooq Bioscience
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. Its affinity to SETD8 was confirmed by ITC (isothermal titration calorimetry) and SPR (surface plasmon resonance) studies.
More Information Supplier PageUNC0379 10mg 10mg | Purity Not Available
Adooq Bioscience
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8. Its affinity to SETD8 was confirmed by ITC (isothermal titration calorimetry) and SPR (surface plasmon resonance) studies.
More Information Supplier PagePX-478 HCl 50mg 50mg | Purity Not Available
Adooq Bioscience
PX-478 is HIF-1alpha inhibitor, is also an orally active small molecule with potential antineoplastic activity. PX-478 has excellent activity against established human tumor xenografts, providing tumor regressions with prolonged growth delays which correlate positively with HIF-1 levels. PX-478 is a highly water soluble molecule, with good i.v., i.p. and p.o. antitumor activity.
More Information Supplier PageNLG919 25mg 25mg | Purity Not Available
Adooq Bioscience
NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.
More Information Supplier PageNLG919 50mg 50mg | Purity Not Available
Adooq Bioscience
NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.
More Information Supplier Page